Position in VRTX
as of Jun 30, 2026
· filed Aug 27, 2026
Position Value
$51,538,220
+$12,916,083 QoQ
Shares Held
103,755
+20.0% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 12%
Shared 3%
None 84%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $248,200,388 across 122 Biotechnology names. VRTX ranks #1 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
103,755 | $51,538,220 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
196,661 | $15,593,250 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
187,166 | $14,649,482 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
30,558 | $11,357,491 | |
| 5 | TECH |
BIO-TECHNE Corp
|
119,590 | $8,449,033 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,473 | $7,777,414 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,969 | $7,215,387 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
176,956 | $6,584,532 |
All Filings in VRTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,538,220 | 103,755 | Shares | Sole | 2026-08-27 | |
| 2026-03-31 | $38,622,137 | 86,492 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $46,501,135 | 102,570 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $39,841,926 | 101,731 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $45,773,681 | 102,816 | Shares | Defined | 2025-09-26 | |
| 2025-03-31 | $51,657,570 | 106,550 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $45,563,893 | 113,146 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $60,118,566 | 129,265 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $72,567,229 | 154,820 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $63,762,825 | 152,539 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $62,037,703 | 152,468 | Shares | Other | 2024-02-09 | |
| 2023-09-30 | $55,723,247 | 160,244 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $60,635,148 | 172,303 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $55,346,771 | 175,665 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $41,967,241 | 145,326 | Shares | Other | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||